Page 19 - Sanket Koul

Indian pharma market grows 7.2% in May led by chronic therapies

Indian pharma market grew 7.2% in May with strong performance in chronic therapies such as cardiac and anti-infectives, along with gains from price hikes and new launches

India's active Covid case tally nears 5K, 7 deaths reported in 24 hours

Among states, Kerala had the highest caseload at 1,487, followed by Delhi and West Bengal with 562 and 538 cases respectively

Harvard visa ban could disrupt fall admissions and set college precedent

President Trump's proclamation empowers the Secretary of State to revoke visas of international students at Harvard, raising concerns for fall admissions and international education policies

Centre to hold nationwide Covid mock drill on June 5 for hospital checks

The Health Ministry will assess hospital readiness through a mock drill on June 5 as Covid-19 cases rise, with states asked to ensure oxygen, beds, and essential supplies

NPPA fixes retail prices for 41 drug combinations, including empagliflozin

The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments, citing steep price drops and growing generic availability

IIT Delhi, AIIMS sign MoU to establish centre to research AI in healthcare

The proposed Centre of Excellence will develop AI-based tools to support key national health programmes and operate as a Section 8 company under a ₹330 crore grant

NEET-PG postponed, to be conducted in single shift after SC order

While hearing a petition last week, the court directed NBEMS not to hold NEET-PG 2025 in two shifts, observing that such a format could create arbitrariness

Infectious variants, viral season behind Covid surge, say experts

Doctors and epidemiologists say infectious subvariants and seasonal viruses are driving the Covid-19 surge, with Kerala, Maharashtra and Delhi reporting most cases

India logs 2,710 active Covid-19 cases, Kerala tops with 1,147 infections

Health ministry data suggests the country saw 168% rise in active Covid cases in the last four days

CDSCO lists 17 drugs safe to flush to prevent harm from misuse at home

Regulator's draft guidance allows flushing of 17 high-risk drugs including opioids; calls for drug take-back sites to curb AMR, environmental and public health risks

Centre to aid development of indigenous thrombectomy device for stroke

Technology Development Board to fund S3V Vascular Technologies for manufacturing India's first thrombectomy device, aiming to reduce import dependency and boost stroke care

Whiteland Corp launches Marriott's first branded residence in Gurugram

Planned investment of ₹5,600 crore and projected topline of ₹15,000 crore, the development will include 1,700 Westin-branded residences with no hotel component

Need to create capacity at secondary, higher secondary levels: Secy

School Education Secretary Sanjay Kumar calls for more secondary and higher secondary schools to address dropout rates and align with NEP 2020 enrolment targets

Trump effect: Visa hurdles, scrutiny may defer Indian students' US dream

The proposed social-media scrutiny and suspension of student visa interviews could lead to delays in the application process for Indian students

India crosses 1,000 active Covid-19 cases, Kerala tops with 430 infections

The country clocked 752 new Covid-19 infections between May 19 and 26, seven deaths reported during the period

University of Liverpool to open Bengaluru campus, start by August 2026

The institute becomes the second UK university after Southampton to get UGC approval; 15 foreign varsities to open India campuses this academic year, says Pradhan

Donald Trump-Harvard battle: American Dream of Indian students at risk

Harvard currently hosts around 10,158 international students and scholars across its schools. Of these, 788 -- the second-largest cohort after China -- are from India, according to university data

From Kerala to Uttar Pradesh, states step up vigil as Covid returns

Masks, tests and advisories return as states like Kerala, UP and Odisha increase vigilance amid rising Covid-19 cases driven by new Omicron sub-variants

Emcure Q4 profit jumps 63%, domestic business drives 19.5% revenue rise

Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance

IHH's move to seek increased damages may not affect Fortis expansion plans

Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over stalled open offer and regulatory hurdles